Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -249.07M
December 31, 2024 -131.76M
December 31, 2023 -110.13M
December 31, 2022 -184.23M
Date Value
December 31, 2021 -123.79M
December 31, 2020 -51.93M
December 31, 2019 -32.79M
December 31, 2018 -20.72M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 827.99M
Insmed, Inc. -935.01M
Vertex Pharmaceuticals, Inc. 3.631B
Ironwood Pharmaceuticals, Inc. 127.04M
Xencor, Inc. -135.12M